The com­ing glut? Can­cer cell ther­a­py tri­als are boom­ing as Chi­na ri­vals US on new projects

The Can­cer Re­search In­sti­tute has been keep­ing a care­ful eye on can­cer R&D as new mon­ey con­tin­ues to pour in­to the field from all di­rec­tions. To­day, in the lead up to AS­CO this week­end, they’ve up­dat­ed their work on can­cer cell ther­a­pies — and as you might ex­pect there’s plen­ty of signs that things are con­tin­u­ing to heat up.

The top high­lights from the new re­port in Na­ture Re­views Drug Dis­cov­ery by Jun Tang and col­leagues

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER